Stay updated on Lumateperone in Schizophrenia Relapse Prevention Clinical Trial
Sign up to get notified when there's something new on the Lumateperone in Schizophrenia Relapse Prevention Clinical Trial page.

Latest updates to the Lumateperone in Schizophrenia Relapse Prevention Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.2 to v3.8.0; the study record content remains unchanged.SummaryDifference0.1%

- Check21 days agoChange DetectedA sitewide NIH notice says websites are transitioning to the term “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference0.7%

- Check28 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check35 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check42 days agoChange DetectedThe ClinicalTrials.gov record now indicates that results are posted and reflects updated study versions, including changes to outcome measures and study status. The history also shows a transition from results submitted to results posted.SummaryDifference2%

- Check56 days agoChange DetectedA new site revision entry v3.7.0 was added to the study record history, and the previous revision v3.6.6 was removed.SummaryDifference0.1%

Stay in the know with updates to Lumateperone in Schizophrenia Relapse Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lumateperone in Schizophrenia Relapse Prevention Clinical Trial page.